Vitrolife AB Statistics

Total Valuation

Vitrolife AB has a market cap or net worth of GBP 1.65 billion. The enterprise value is 1.72 billion.

Market Cap	1.65B
Enterprise Value	1.72B

Important Dates

The next estimated earnings date is Thursday, July 17, 2025.

Earnings Date	Jul 17, 2025
Ex-Dividend Date	Apr 30, 2025

Share Statistics

Current Share Class	135.42M
Shares Outstanding	n/a
Shares Change (YoY)	+0.10%
Shares Change (QoQ)	-0.21%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	75.04M

Valuation Ratios

The trailing PE ratio is 42.92 and the forward PE ratio is 35.91.

PE Ratio	42.92
Forward PE	35.91
PS Ratio	5.92
PB Ratio	1.63
P/TBV Ratio	n/a
P/FCF Ratio	31.20
P/OCF Ratio	27.47
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.58, with an EV/FCF ratio of 32.51.

EV / Earnings	44.72
EV / Sales	6.18
EV / EBITDA	18.58
EV / EBIT	28.82
EV / FCF	32.51

Financial Position

The company has a current ratio of 3.77, with a Debt / Equity ratio of 0.15.

Current Ratio	3.77
Quick Ratio	2.98
Debt / Equity	0.15
Debt / EBITDA	1.62
Debt / FCF	2.85
Interest Coverage	8.41

Financial Efficiency

Return on equity (ROE) is 3.78% and return on invested capital (ROIC) is 3.18%.

Return on Equity (ROE)	3.78%
Return on Assets (ROA)	2.89%
Return on Invested Capital (ROIC)	3.18%
Return on Capital Employed (ROCE)	4.83%
Revenue Per Employee	242,050
Profits Per Employee	33,391
Employee Count	1,169
Asset Turnover	0.22
Inventory Turnover	3.64

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -13.72% in the last 52 weeks. The beta is 1.83, so Vitrolife AB's price volatility has been higher than the market average.

Beta (5Y)	1.83
52-Week Price Change	-13.72%
50-Day Moving Average	160.35
200-Day Moving Average	209.01
Relative Strength Index (RSI)	50.15
Average Volume (20 Days)	53,058

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Vitrolife AB had revenue of GBP 278.36 million and earned 38.40 million in profits. Earnings per share was 0.28.

Revenue	278.36M
Gross Profit	165.16M
Operating Income	59.68M
Pretax Income	51.74M
Net Income	38.40M
EBITDA	88.83M
EBIT	59.68M
Earnings Per Share (EPS)	0.28

Full Income Statement

Balance Sheet

The company has 81.27 million in cash and 150.44 million in debt, giving a net cash position of -69.17 million.

Cash & Cash Equivalents	81.27M
Total Debt	150.44M
Net Cash	-69.17M
Net Cash Per Share	n/a
Equity (Book Value)	1.01B
Book Value Per Share	7.47
Working Capital	129.08M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 59.99 million and capital expenditures -7.17 million, giving a free cash flow of 52.82 million.

Operating Cash Flow	59.99M
Capital Expenditures	-7.17M
Free Cash Flow	52.82M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 59.34%, with operating and profit margins of 21.44% and 13.80%.

Gross Margin	59.34%
Operating Margin	21.44%
Pretax Margin	18.59%
Profit Margin	13.80%
EBITDA Margin	31.91%
EBIT Margin	21.44%
FCF Margin	18.98%

Dividends & Yields

This stock pays an annual dividend of 0.09, which amounts to a dividend yield of 0.05%.

Dividend Per Share	0.09
Dividend Yield	0.05%
Dividend Growth (YoY)	16.40%
Years of Dividend Growth	2
Payout Ratio	27.11%
Buyback Yield	-0.10%
Shareholder Yield	-0.04%
Earnings Yield	2.33%
FCF Yield	3.20%

Dividend Details

Stock Splits

The last stock split was on May 17, 2018. It was a forward split with a ratio of 5.

Last Split Date	May 17, 2018
Split Type	Forward
Split Ratio	5

Scores

Vitrolife AB has an Altman Z-Score of 5.17.

Altman Z-Score	5.17
Piotroski F-Score	n/a